Corporate venture firms MP Healthcare Venture Management and Merck Serono Ventures have co-led an extended series-A round for f-star Biotechnologische Forschungs- und Entwicklungsges mbH.
This article is only available to subscribers to unquote.com
Sign up
Subscribe
unquote.com is your your online gateway to our market-leading European private equity information. Subscribe today to gain immediate access to unquote.com's premium content.